Presbia (LENS) Stock Price, News & Analysis

Company Overview

Presbia PLC is a holding company. It engages in the development and marketing of presbyopia-correcting solutions under the trademark of Presbia Flexivue Microlens. It operates through the Restoration of Clear Vision Caused by Presbyopia segment. The company was founded on February 2, 2014 and is headquartered in Dublin, Ireland.

Key Stats

• Today's Range: $25.10 to $25.27
• 50-Day Range: $0.07 to $0.32
• 52-Week Range: $0.23 to $5.50
• Volume: 300 shs
• Average Volume: 122,366 shs
• Market Capitalization: $433.55 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LENS Stock Analysis - Frequently Asked Questions

How were Presbia's earnings last quarter?

Presbia PLC (NASDAQ:LENS) posted its quarterly earnings results on Friday, August, 12th. The medical instruments supplier reported ($0.32) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.25) by $0.07. The medical instruments supplier earned $0.01 million during the quarter, compared to analyst estimates of $0.04 million. Presbia had a negative net margin of 36,604.35% and a negative trailing twelve-month return on equity of 414.02%.

When did Presbia IPO?

Presbia (LENS) raised $50 million in an initial public offering on Thursday, January 29th 2015. The company issued 4,200,000 shares at $11.00-$13.00 per share. Jefferies acted as the underwriter for the IPO.

What other stocks do shareholders of Presbia own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Presbia investors own include Ritter Pharmaceuticals (RTTR), AcelRx Pharmaceuticals (ACRX), Allena Pharmaceuticals (ALNA), Bellatrix Exploration (BXE), Second Sight Medical Products (EYES), Lilis Energy (LLEX) and Marinus Pharmaceuticals (MRNS).

Company Calendar

• Last Earnings: 8/12/2016
• Today: 3/12/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & Medical Instruments
• Sub-Industry: N/A
• Current Symbol: NASDAQ:LENS
• CIK: 1591096
• Web: www.presbia.com
• Phone: (531) 551-1487
• Fax: N/A
• Employees: 24
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-8,410,000.00
• Net Margins: -36,604.35%
• Pretax Margin: N/A
• Return on Equity: -414.02%
• Return on Assets: -195.56%

Debt

• Debt-to-Equity Ratio: 1.24
• Current Ratio: 2.88
• Quick Ratio: 2.82

Sales & Book Value

• Annual Sales: $20,000.00
• Price / Sales: 21,677.67
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.09 per share
• Price / Book: 279.59

Miscellaneous

• Outstanding Shares: 17,230,000
• Free Float: N/A
• Market Cap: $433.55 million
• Optionable: Not Optionable
• Beta: 2.57